Eli Lilly Alzheimer's Drug Delayed as FDA Plans Advisory Panel Meeting

Eli Lilly said theFDA would hold an advisory committee meeting on its proposed Alzheimer's disease drug donanemab, likely delaying the agency's decision on whether to approve the drug. 


 
Unless You're Nvidia, the AI Chip Business Is Complicated

Broadcom and Marvell shares have surged on AI hype, but other chip segments weigh on results. 


 
Rivian Follows Tesla's Lead, but Is It Too Late?

While the EV startup can serve more customers with a $45,000 sport-utility vehicle, the market is getting crowded. 


 
BP Claws Back $2.3 Million From Ex-CEO

BP clawed back a further $2.3 million from ex-boss Bernard Looney's remuneration package following his dismissal in December. 


 
Prada Soars After Jump in Sales, Profit

Prada gained about $2.7 billion in market value after annual profit and sales surged past analysts' expectations, outperforming other European luxury-goods firms that are grappling with a slowdown in the industry. 


 
Airlines Train Pilots to Manage GPS Tampering

Incidents of GPS spoofing and jamming started rising in 2022, often near conflict zones. 


 
TikTok Stunt Motivates Lawmakers to Take On the App

U.S. lawmakers are mounting their most serious attempt to effectively either ban popular video app TikTok or separate it from its Chinese owner, advancing a bill that has more political momentum than previous attempts. 


 
Boeing to Tie More of Employees' Incentive Pay to Safety

The jet maker is overhauling how it pays employee bonuses to emphasize quality and safety over meeting financial targets. 


 
TikTok Backlash as Congress Heads for Vote to Force Sale

Lawmakers advanced a bill calling on the popular video-sharing app's parent to divest of it. 


 
Marvell's stock drops as AI momentum is outweighed by pressure elsewhere

Marvell's earnings outlook underwhelmed as the company called out "soft" demand in certain categories.


(END) Dow Jones Newswires

03-08-24 0915ET